EVAX
Evaxion AS
NASDAQ · Healthcare · Biotechnology · DK
$3.27
+1.55%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 106.67x
- P/S forward
- 49.58x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.10x
- Price / sales
- 3.94x
- Price / cash flow
- —
Enterprise value
- Enterprise value
- $22.6M
- EV / sales
- 3.02x
- EV / EBITDA
- -2.28x
- EV / EBIT
- -2.60x
- Market cap
- $29.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026